Cargando…
A comparative study of bloodstream infections in acute myeloid leukemia according to different phases of treatment: Can we predict the organism?
INTRODUCTION: The treatment of acute myeloid leukemia (AML) consists of induction therapy with anthracyclines and cytarabine followed by two to four cycles of consolidation therapy with high-dose cytarabine after achieving remission. There have been very few studies comparing infections during induc...
Autores principales: | Kalaskar, Preetam, Anand, Asha, Panchal, Harsha, Patel, Apurva, Parikh, Sonia, Shah, Sandip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615885/ https://www.ncbi.nlm.nih.gov/pubmed/28975124 http://dx.doi.org/10.4103/2278-330X.214584 |
Ejemplares similares
-
Immunosuppressive therapy for aplastic anemia: a single-center experience from western India
por: Shah, Sandip, et al.
Publicado: (2018) -
Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase
por: Linga, Vijay Gandhi, et al.
Publicado: (2014) -
Regulation of human T-cell leukemia virus type 1 antisense promoter by myocyte enhancer factor-2C in the context of adult T-cell leukemia and lymphoma
por: Madugula, Kiran K., et al.
Publicado: (2022) -
Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment
por: Satyarth, Satyam, et al.
Publicado: (2017) -
Obesity and the Risk for a Hematological Malignancy: Leukemia, Lymphoma, or Myeloma
por: Lichtman, Marshall A.
Publicado: (2010)